-
COP31 Presidency Publishes First Draft Cover Decision on Climate Action
-
BYD Dolphin G Leasing Deal: Plug-in Hybrid Supermini Available from £174 a Month
-
EU Club Group Files Antitrust Complaint Against UEFA Over Prize Money
-
Egypt Opens Registration for 2027 Total Solar Eclipse Viewing Packages
-
Heat and El Niño Drive Surge in Preterm Births Across Southern Africa
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Tom Brady’s Viral Reaction to Deebo Samuel’s Trick-Play Touchdown
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
13 Native American-Owned Restaurants in Arizona to Experience Indigenous Culinary Traditions
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Best Digital Photo Frames 2026: Aura, Skylight, and Amazon Compared
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Colin Farrell and Emma Fogarty on Friendship, Disability, and 'The Slightest Touch'
-
Helen Rees Reflects on Four Decades of South Africa's HIV Journey
-
Knicks Coach Mike Brown Unfazed by Josh Hart's Offensive Struggles
-
Foreign Investors Return to Indian Equities with ₹84,290 Crore Inflow
Pfizer in talks on $5 billion acquisition: media
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Pfizer, one of the top makers of Covid-19 vaccines, hopes to conclude talks with GBT within days, the newspaper said Friday, citing people close to the negotiations.
But it said other takeover candidates remain in the running.
GBT's sickle-cell treatment, marketed as Oxbryta, was authorized for those over 12 years old in 2019 but gained federal approval in December for children aged four to 11. The blood disorder affects millions.
Sales of Oxbryta helped the laboratory generate first-quarter turnover of $55 million (up 41 percent), while the company registered a net loss of $81.4 million.
GBT, which is based in San Francisco, California, is to publish its second-quarter numbers on Monday.
Pfizer, for its part, saw its second-quarter turnover jump by 47 percent -- to a record $27.74 billion -- boosted by sales of its Covid vaccine and pills.
Its net profit soared by 78 percent, to $9.9 billion.
GBT shares on the New York Stock Exchange were up 33.03 percent at the close on Friday, at $63.84, for a market capitalization of more than $4 billion.
Pfizer shares slipped by 1.18 percent, to $49.27.
M.Ouellet--BTB